HHS · no agency ID · record R0821

Quality Surveillance Dashboard (QSD)

Department of Health and Human Services · HHS/FDA/CDER

Overview

Development stage: DeployedSource: c) Deployed – The use case is being actively authorized or utilized to support the functions or mission of an agency.
High-impact designation: Not high-impactSource: c) Not high-impact
Impact justification: Not reported
Start date: 2023-03 (month precision)Source: Mar-23
Withheld from public reporting: NoSource: a) No

Mission

Topic area: Health and Medical
Operational functions: Document processing and extraction Derived by keyword rules; see methodology

Problem the AI is intended to solve

Need for consistent, data-driven assessment of drug manufacturing facilities and proactive detection of potential quality signals that could indicate problems with drug safety or effectiveness.

Expected benefits

Extracts unstructured text from documents and pools that with other available data to form a dashboard that enables consistent assessment of Center for Drug Evaluation and Research (CDER) regulated manufacturing facilities, supporting FDA's oversight of drug quality.

System outputs

Identifies and extracts keywords/phrases from unstructured documents and presents sentences containing keywords/phrases in context.

Technology

AI classification: Natural language processingSource: Natural Language Processing: AI that processes, interprets, and shares information in human language.
System name(s): CDEROne Analytics: FISMA-high environment
Custom-developed code: Yes
Public source code: Not reported

Sourcing

How it was built: Contract and in-houseSource: c) Developed with both contracting and in-house resources
Vendor (as reported): In-house (CDER staff)
Vendors (standardized): None on the standard list

A vendor is the supplier named by the agency. It does not identify the underlying model or AI technology.

Data and privacy

Involves PII: No
Privacy Impact Assessment: Not reported
Authorization to Operate: Yes
Demographic features: k) None of the above
Training and evaluation data: FDA EIR documents
Federal Data Catalog: Not reported

Governance

0 of 8 minimum-practice questions answered. A blank answer means the agency reported nothing; it does not mean the practice is absent.

Pre-deployment testingNo answer reported

AI impact assessmentNo answer reported

Independent reviewNo answer reported

Ongoing monitoringNo answer reported

Operator trainingNo answer reported

Fail-safeNo answer reported

Appeal processNo answer reported

User and public consultationNo answer reported

Potential impacts and how they were identified

Not reported